View in EDS HTML Full Text PDF Full Text

A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.

Saved in:
Bibliographic Details
Title: A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.
Authors: McKenzie, Andrew1 (AUTHOR) Andrew.McKenzie@csl.com.au, Roberts, Anthony1 (AUTHOR), Malandkar, Sourabh1 (AUTHOR), Feuersenger, Henrike2 (AUTHOR), Panousis, Con1 (AUTHOR), Pawaskar, Dipti3 (AUTHOR)
Source: CTS: Clinical & Translational Science. Mar2022, Vol. 15 Issue 3, p626-637. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 155835718
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22McKenzie%2C+Andrew%22">McKenzie, Andrew</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Andrew.McKenzie@csl.com.au</i><br /><searchLink fieldCode="AR" term="%22Roberts%2C+Anthony%22">Roberts, Anthony</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Malandkar%2C+Sourabh%22">Malandkar, Sourabh</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feuersenger%2C+Henrike%22">Feuersenger, Henrike</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Panousis%2C+Con%22">Panousis, Con</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pawaskar%2C+Dipti%22">Pawaskar, Dipti</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22CTS%3A+Clinical+%26+Translational+Science%22">CTS: Clinical & Translational Science</searchLink>. Mar2022, Vol. 15 Issue 3, p626-637. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=155835718
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.13180
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 626
    Titles:
      – TitleFull: A phase I, first‐in‐human, randomized dose‐escalation study of anti‐activated factor XII monoclonal antibody garadacimab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McKenzie, Andrew
      – PersonEntity:
          Name:
            NameFull: Roberts, Anthony
      – PersonEntity:
          Name:
            NameFull: Malandkar, Sourabh
      – PersonEntity:
          Name:
            NameFull: Feuersenger, Henrike
      – PersonEntity:
          Name:
            NameFull: Panousis, Con
      – PersonEntity:
          Name:
            NameFull: Pawaskar, Dipti
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 17528054
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: CTS: Clinical & Translational Science
              Type: main
ResultId 1